Report - Medical Developments Int Ltd (MVP) 27 June 2019...term growth potential of a global roll-out of Penthrox. Our valuation range is $5.39 to $7.52 per share, with a mid-point of $6.45

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form